Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2590)
All Articles published online
|
Dec 21, 2008 (publication date) through Jan 7, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tsubota A, Satoh KI, Aizawa M, Takamatsu S, Namiki Y, Ohkusa T, Fujise K, Tajiri H. Four-week pegylated interferon α-2a monotherapy for chronic hepatitis C with genotype 2 and low viral load: A pilot, randomized study. World J Gastroenterol 2008; 14(47): 7220-7224 [PMID: 19084937 DOI: 10.3748/wjg.14.7220] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i47/7220.htm |
| Number | Citing Articles |
| 1 |
Yi-Wen Huang, Albert Qin, Chan-Yen Tsai, Pei-Jer Chen. Novel Pegylated Interferon for the Treatment of Chronic Viral Hepatitis. Viruses 2022; 14(6): 1128 doi: 10.3390/v14061128
|
| 2 |
Keizo Kato, Takeshi Yonezawa, Chizuko Tachibana, Hiroyuki Tachibana, Satoshi Watanabe, Yasushi Mandai, Rei Kashima, Kazushi Fukuda. Response-guided therapy based on reaction to the initial dose using administration of peginterferon α-2a alone or in combination with ribavirin in naïve patients with chronic hepatitis C of serotype 2 and high viral loads. Kanzo 2012; 53(1): 18 doi: 10.2957/kanzo.53.18
|